Growth is strong; the funding model deserves equal attention. FY2027 core EPS guidance grows34%, while adjusted free cash flow grows4%. Huge operating-asset cash needs were offset by liability funding. Our three valuation routes support $300, below the $318.84 pre-print reference. Require better cash conversion or a wider entry margin.
Analyst twelve-month scenario values; not management guidance or statistical probabilities.
| Scenario | Value |
|---|---|
| Bear | 180 |
| Base | 300 |
| Bull | 425 |
| Weighted | 301.25 |
| Scenario | Probability | 12-month value | vs $318.84 | What has to happen | The arithmetic |
|---|---|---|---|---|---|
| Bear | 25% | $180.00 | −44% | Cash conversion disappoints and customers delay programs; a lower earnings base and multiple compound. | Analyst normalized core EPS $12 ×15 = $180; weaker than company guidance. |
| Base | 50% | $300.00 | −6% | The guided ramp largely succeeds; cash matures gradually and economic costs remain in the valuation. | Three routes: $315.90 earnings, $301.26 economic EBIT, $290.00 owner DCF; central judgment $300. |
| Bull | 25% | $425.00 | +33% | Collections improve, infrastructure demand lasts and per-share cash performance earns a premium. | Analyst core EPS $21.25 ×20 = $425; above current company guidance. |
| Weighted value $301.25 =25% ×$180 +50% ×$300 +25% ×$425. Outcomes can fall outside this range; the $300 base is a central judgment, not the weighted value. | |||||
| Signpost | Now (Q4 FY2026) | Green if | Red if | Next check |
|---|---|---|---|---|
| Q1FY2027 revenue | $10.6–$11.4B guide | Within/above range | Below$10.6B | Dec2026 review |
| Q1core EPS | $3.80–$4.20 guide | Within/above range | Below$3.80 | Dec2026 review |
| FY2027 adjusted FCF | ~$1.6B guide | Maintained/raised | Below$1.5B | Next FY2027 update;Dec2026 review |
| Net funded debt | $1.64B | At/below$1.64B with cash progress | Above$2.0B | Next filing;Dec2026 review |
| Funding mechanics | $7.984B liability inflow | Explained and durable terms | New unresolved obligations | FY2026 10-K;Oct2026 review |
| Entry price | $318.84 reference | At/below$240 with intact thesis | Thesis breaks at any price | Continuous;Dec2026 formal review |
These are dated analyst review triggers. Earnings dates are not confirmed appointments; preserve this baseline for next-quarter grading.
The valuation anchor is the September 29 pre-print close of $318.84. Our saved September 30 intraday quote is about $304.20, down about 4.6% against that previous close, and is a changing observation rather than a completed-session return. All multiples and scenario comparisons in this packet consistently use the pre-print anchor. This avoids quietly changing the denominator between a company result and a valuation conclusion. The release occurred before the market opened; the conference-call time is a separate event, not proof of the release timestamp.
The investment question has shifted from whether demand exists to who supplies the cash required to fulfill it. A manufacturer can earn more while tying up much more money in customer balances and components. Supplier terms, customer advances and the timing of collections can bridge that gap, but those arrangements must remain available as production ramps. Revenue growth alone does not tell us how much incremental cash belongs to shareholders. A falling share price on an apparently strong report can reflect that distinction, although a single session cannot establish investors' motives.
The reference equity value is $33.41 billion using 104.787 million current outstanding shares from the saved provider snapshot. Adding $1.64 billion of net funded debt produces an enterprise value of $35.05 billion. The shares field is a current outstanding-share proxy, not the annual diluted weighted average. Warrants and equity compensation can change future dilution, so none of our scenarios assumes buybacks will automatically reduce the denominator. Price history is unadjusted closing-price context and should not be read as a total-return series.
| Date | Close |
|---|---|
| 2025-06-02 | $168.02 |
| 2025-08-06 | $220.68 |
| 2025-10-09 | $204.71 |
| 2025-12-12 | $222.37 |
| 2026-02-19 | $262.44 |
| 2026-04-24 | $341.65 |
| 2026-06-30 | $385.48 |
| 2026-09-02 | $299.39 |
| Measure | Value | Basis |
|---|---|---|
| Price | $318.84 | Sep29 pre-print close |
| Current shares | 104.787M | Saved provider snapshot; not diluted annual average |
| Equity capitalization | $33,410M | Price × current shares |
| Funded debt | $3,379M | Current plus long term |
| Cash | $1,739M | August31 balance |
| Net debt | $1,640M | Debt minus cash |
| Enterprise value | $35,050M | Equity plus net debt |
Jabil reported fourth-quarter revenue of $10.616 billion, up 28.6% from $8.252 billion. Core operating income rose 30.1% to $675 million, while GAAP operating income increased to $602 million from $337 million. Core diluted earnings per share reached $4.40, up 33.7%; GAAP diluted earnings per share were $3.76. These measures describe the same quarter but answer different questions. Core results strip out selected expenses, whereas GAAP includes the charges actually recognized in the income statement.
The sales acceleration is unmistakable across the recent history. Revenue advanced from $8.305 billion in the first quarter to $8.282 billion in the second, $8.751 billion in the third and $10.616 billion in the fourth. That sequence does not by itself prove organic growth because acquisitions, customer mix and component pass-through can all change reported sales. The quarter also had a stronger profit conversion than a simple low-margin volume surge: core operating profit grew slightly faster than sales. Still, the rounded core margin was only 6.4%, versus 6.3% a year earlier. Small margin changes matter when the revenue base is this large.
For the fiscal year, revenue was $35.954 billion and core operating income was $2.069 billion. The fiscal-year statements in this release are preliminary and unaudited; the current annual filing had not yet appeared in the saved SEC submissions. We use the release for the new results and the already-filed annual and quarterly reports for accounting context. Later audited footnotes could refine the picture without negating the existence of today's verified earnings print.
| Period | Revenue |
|---|---|
| Q4 FY2024 | 6,964.00 |
| Q1 FY2025 | 6,994.00 |
| Q2 FY2025 | 6,728.00 |
| Q3 FY2025 | 7,828.00 |
| Q4 FY2025 | 8,252.00 |
| Q1 FY2026 | 8,305.00 |
| Q2 FY2026 | 8,282.00 |
| Q3 FY2026 | 8,751.00 |
| Q4 FY2026 | 10,616.00 |
| Period | GAAP EPS | Core EPS |
|---|---|---|
| Q4 FY2024 | 1.18 | 2.30 |
| Q1 FY2025 | 0.88 | 2.00 |
| Q2 FY2025 | 1.06 | 1.94 |
| Q3 FY2025 | 2.03 | 2.55 |
| Q4 FY2025 | 1.99 | 3.29 |
| Q1 FY2026 | 1.35 | 2.85 |
| Q2 FY2026 | 2.08 | 2.69 |
| Q3 FY2026 | 2.59 | 3.16 |
| Q4 FY2026 | 3.76 | 4.40 |
| Measure | Q4 FY2025 | Q4 FY2026 |
|---|---|---|
| Revenue | $8,252M | $10,616M |
| Gross profit | $783M | $1,001M |
| Operating income | $337M | $602M |
| Core operating income | $519M | $675M |
| Parent net income | $218M | $398M |
| GAAP diluted EPS | $1.99 | $3.76 |
| Core diluted EPS | $3.29 | $4.40 |
The current release does not provide a fourth-quarter segment revenue and profit table. We therefore show the latest filed segment detail, for the third quarter ended May 31, and label it explicitly. We do not call those figures fourth-quarter results or estimate a missing breakdown from consolidated growth. The three reportable segments are Regulated Industries, Intelligent Infrastructure, and Connected Living and Digital Commerce. The annual filing recasts comparative segment history onto this reporting basis, which matters when comparing older classifications.
In that latest filed quarter, Intelligent Infrastructure produced $4.169 billion of revenue and $256 million of segment income. Regulated Industries produced $3.181 billion and $180 million; Connected Living and Digital Commerce produced $1.401 billion and $68 million. The infrastructure segment was nearly half the revenue base. These operating categories contain more than a single end market, so it would be wrong to rename all infrastructure revenue as artificial intelligence revenue. Conversely, strong infrastructure demand can support related power and cooling work outside an oversimplified product label.
This distinction is useful for evaluating the next year. Management describes demand in artificial intelligence as well as automotive, healthcare, energy, defense and aerospace, and warehouse and retail automation. Those are management's stated markets, not a promise that every category will expand at the consolidated growth rate. The highest-value follow-up is the next disclosed segment margin and working-capital detail. A larger infrastructure contribution is attractive if it earns adequate returns on the inventory, facilities and customer credit needed to serve that demand.
| Period | Revenue |
|---|---|
| Regulated Industries | 3,181.00 |
| Intelligent Infrastructure | 4,169.00 |
| Connected Living and Digital Commerce | 1,401.00 |
| Period | Segment income |
|---|---|
| Regulated Industries | 180.00 |
| Intelligent Infrastructure | 256.00 |
| Connected Living and Digital Commerce | 68.00 |
| Segment | FY2024 revenue | FY2025 revenue | FY2025 income |
|---|---|---|---|
| Regulated Industries | $12,261M | $11,879M | $643M |
| Intelligent Infrastructure | $9,197M | $12,317M | $664M |
| Connected Living / Digital Commerce | $7,425M | $5,606M | $313M |
| FY2025 10-K recast reporting basis; current Q4 breakdown not supplied. | |||
The latest quarter's gap between GAAP and core operating income was $73 million. It comprised $24 million of amortization, $25 million of stock compensation and related charges, $9 million of restructuring, $5 million of net periodic benefit cost, and $10 million of acquisition and divestiture charges. That bridge reconciles $602 million of GAAP operating income to $675 million of core operating income. It is smaller than the prior-year quarter's $182 million bridge, which included a substantial business-divestiture loss. Accordingly, faster GAAP profit growth does not mean that recurring operating economics accelerated by the same percentage.
At the full-year level, $365 million of adjustments separate $1.704 billion of GAAP operating income from $2.069 billion of core operating income. The largest ordinary economic issue is not whether the reconciliation is disclosed; it is how much of the excluded cost should remain in a shareholder valuation. Equity compensation transfers value and can create dilution. Acquisition amortization is noncash in the current period but follows an earlier cash investment. Recurring restructuring can also be an ongoing cost of maintaining a manufacturing footprint.
Our enterprise-value route starts with management's forward core operating-margin objective, then subtracts an explicit $160 million annual equity-compensation reserve. That reserve is an analyst assumption, not company guidance or a claim that this is the only adjustment needed. The earnings-multiple route deliberately uses the familiar core EPS guide as a separate market comparison. Keeping the routes distinct makes the sensitivity visible instead of blending adjusted earnings and unadjusted cash without explanation.
| Period | GAAP | Core |
|---|---|---|
| Q4 FY2025 | 337.00 | 519.00 |
| Q4 FY2026 | 602.00 | 675.00 |
| FY2025 | 1,182.00 | 1,620.00 |
| FY2026 | 1,704.00 | 2,069.00 |
| Item | USD millions |
|---|---|
| GAAP operating income | 602 |
| Amortization | 24 |
| Stock compensation and related | 25 |
| Restructuring | 9 |
| Net periodic benefit cost | 5 |
| Acquisition/divestiture charges | 10 |
| Total adjustments | 73 |
| Core operating income | 675 |
| Period | FY2026 adjustments |
|---|---|
| Amortization | 89.00 |
| SBC | 140.00 |
| Restructuring | 97.00 |
| Benefit | 4.00 |
| Divestiture | 1.00 |
| Acquisition | 34.00 |
A strong result can coexist with an important funding dependency. The quality assessment therefore separates recognized profit, collections, inventory exposure, supplier terms, accounting adjustments and dilution. None of the figures reviewed establishes fraud or a restatement. The issue is the durability of cash conversion when several very large working-capital balances grow at once. Describing every payable increase as debt financing would also be inaccurate: ordinary trade credit is part of this business model, and the release groups multiple liabilities in the cash-flow bridge.
Receivables were $6.513 billion at year-end, inventory was $7.413 billion and accounts payable was $14.444 billion. Ending-balance proxies using a ninety-two-day quarter imply about 56 receivable days, 71 inventory days and 138 payable days. These are analytical ratios, not the company's reported cash-conversion cycle. They use ending balances rather than averages, receivables can exclude balances sold to financial institutions, and the release does not provide the purchase denominator needed for a precise payable-days calculation. Acquisitions and seasonality further limit direct comparison.
The annual and quarterly filings describe accounts-receivable sale arrangements whose proceeds enter operating cash flow. At the prior fiscal year-end, outstanding sold balances with continuing involvement included $372 million under the global securitization program and $927 million under other sale programs. The current fourth-quarter release does not refresh those footnotes. We therefore flag collection financing for follow-up without extrapolating those old balances into the new year-end. Reported cash flow is useful, but the financing arrangements behind it deserve the same attention as the earnings headline.
| Period | FY2025 | FY2026 |
|---|---|---|
| Receivables | 4,039.00 | 6,513.00 |
| Inventory | 4,681.00 | 7,413.00 |
| Accounts payable | 7,937.00 | 14,444.00 |
Fiscal-year operating cash flow was $2.002 billion. Before working-capital movements, the cash-flow reconciliation contributes $1.864 billion. Operating assets then absorbed $7.846 billion, including receivables, contract assets, inventory, prepaid and other current assets, and other assets. The grouped accounts-payable, accrued-expense and other-liability movement supplied $7.984 billion. The net working-capital contribution was therefore only $138 million. This is the central finding: the headline cash result rests on two enormous offsetting movements, rather than on an absence of funding pressure.
That does not make the cash unreal. Supplier credit and customer-linked arrangements can be a sensible way to support a contracted manufacturing ramp. It does make the next period more sensitive to timing. If collections improve while liabilities remain stable, cash conversion could become much stronger. If customer payments slow or supplier terms tighten, the same high-growth revenue trajectory could consume cash. The size of the balances means that a relatively small change in days can matter more than another small improvement in the operating margin.
The company's adjusted free cash flow was $1.532 billion. Its calculation subtracts $628 million of property and equipment purchases from operating cash flow and adds $158 million of proceeds and advances from property and equipment sales. A simpler gross-capex measure is $1.374 billion. Both are disclosed here because the extra proceeds are a real cash source but are not interchangeable with recurring customer collections. Cash acquisitions of $852 million, treasury-stock purchases of $1.060 billion and dividends of $35 million also compete for funding outside that adjusted free-cash-flow headline. Cash ended the year $194 million lower despite stronger earnings.
| Period | Operating cash flow | Gross-capex FCF | Adjusted FCF |
|---|---|---|---|
| 2024 | 1,716.00 | 932.00 | 1,055.00 |
| 2025 | 1,640.00 | 1,172.00 | 1,318.00 |
| 2026 | 2,002.00 | 1,374.00 | 1,532.00 |
| Bridge | USD millions |
|---|---|
| Before working capital | 1864 |
| Operating asset cash use | −7846 |
| Liability funding | 7984 |
| Operating cash flow | 2002 |
| Cash flow | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
| Operating cash | $1,716M | $1,640M | $2,002M |
| Gross capex | $784M | $468M | $628M |
| PP&E proceeds/advances | $123M | $146M | $158M |
| Treasury-stock purchases | $2,500M | $1,000M | $1,060M |
| Dividends | $42M | $36M | $35M |
| Stock compensation | $89M | $107M | $140M |
Our central fair value is $300 per share, with HOLD, three-out-of-five conviction and High uncertainty. This is an analyst judgment across three independent approaches, not a price target copied from consensus. It is modestly below the pre-print reference and does not offer the twenty-percent margin of safety we would prefer for a new position facing significant cash-conversion uncertainty. A price near $240 would prompt a fresh review only if the earnings and funding thesis remained intact. A falling price caused by a broken business case would not automatically create a bargain.
The earnings route applies eighteen times management's $17.55 fiscal-year core EPS objective, yielding $315.90. That route is transparent and familiar but gives full credit to a non-GAAP forecast. The enterprise route takes $44.5 billion of guided sales at a 6.1% core operating margin, deducts our $160 million equity-compensation reserve, applies thirteen times the resulting economic operating profit, subtracts $1.64 billion of net debt, and divides by 104.787 million shares. The result is $301.26 per share. Lease obligations remain outside the funded-debt bridge and the selected operating multiple must be interpreted consistently with that treatment.
The cash-flow route starts with $1.450 billion of equity-owner cash flow after interest, below the company's $1.600 billion adjusted free-cash-flow objective. We project fifteen-percent annual growth for the next four steps, discount at ten percent and use three-percent terminal growth. The result is $290.00 per share. Because this is equity cash flow after interest, we do not subtract net debt again. The terminal value is a large share of the result, making the discount rate and long-term cash-growth assumptions consequential. A slower ten-percent growth path lowers this route to about $248 per share. These are assumptions to challenge, not observed facts.
| Period | USD/share |
|---|---|
| Core EPS | 315.90 |
| Economic EBIT | 301.26 |
| Owner cash DCF | 290.00 |
| Central judgment | 300.00 |
| Route | Inputs | Per share |
|---|---|---|
| Core EPS | $17.55 × 18 | $315.90 |
| Economic EBIT | ($44,500M ×6.1% −$160M) ×13 −$1,640M; /104.787M | $301.26 |
| Equity DCF | $1,450M first year;15% growth4steps;10% discount;3% terminal | $290.00 |
| Central value | Judgment across the three routes | $300.00 |
| Reverse EPS | $318.84 /18 | $17.71 |
| Reverse cash | Same DCF assumptions; implied first-year owner cash | $1,594M |
| EPS | 16× | 18× | 20× |
|---|---|---|---|
| 15.5 | 248.0 | 279.0 | 310.0 |
| 17.55 | 280.8 | 315.9 | 351.0 |
| 19.5 | 312.0 | 351.0 | 390.0 |
The saved provider target consensus is $440.75, with a $375 low and a $475 high. That is much more optimistic than our $300 central value. These are heterogeneous analyst targets, typically reflecting individual horizons and assumptions; averaging them does not create an independent valuation model. The dated observations available in the source snapshot precede this earnings release. They must not be presented as analysts' response to today's new guidance, and an updated consensus could move after firms publish their revisions.
The usable firm-level entries include Goldman Sachs at $375 on September 8, Argus at $475 on June 18, and Raymond James at $450 on June 18. One separate provider row has a firm label that conflicts with its own headline; we exclude that ambiguous observation from the named comparison. Preserving the raw snapshot makes that quality decision reviewable. A target's precision should not obscure uncertainty about the source's timing or definition.
The saved fiscal-year 2027 consensus revenue estimate is approximately $42.825 billion and core-like EPS is $16.87. Management's $44.5 billion revenue and $17.55 core EPS objectives are about four percent above those snapshots. The provider does not establish a perfectly matched accounting basis for every estimate, so this is a directional context comparison rather than a clean same-definition beat. The key disagreement is valuation and cash conversion, not a denial of the stronger sales outlook. Our model also assumes substantial cash growth beyond the first year; the lower value comes from explicit cash and compensation discipline.
| Period | Consensus revenue | Management revenue |
|---|---|---|
| Revenue growth context | 42,824.81 | 44,500.00 |
| Firm / source | Date | Target | Timing |
|---|---|---|---|
| Goldman Sachs / FMP news | 2026-09-08 | $375 | Pre-print |
| Argus Research / FMP news | 2026-06-18 | $475 | Pre-print |
| Raymond James / FMP news | 2026-06-18 | $450 | Pre-print |
| Provider target average | Snapshot Sep30 | $440.75 | Mixed prior dates |
| Charged Alpha | 2026-09-30 | $300 | Current cash-conversion thesis |
Management's fiscal-year 2027 plan calls for $44.5 billion of revenue, a 6.1% core operating margin, $17.55 of core EPS and approximately $1.6 billion of adjusted free cash flow. Relative to the newly reported year, that means revenue growth of 23.8%, core EPS growth of 34.1%, but adjusted free-cash-flow growth of only 4.4%. The difference is the episode's most useful forward-looking tension. It could reflect deliberate investment ahead of a larger earnings stream. It could also leave less protection if the ramp takes longer or customers change their schedules.
The first-quarter ranges provide an earlier test: revenue of $10.6 billion to $11.4 billion, core operating income of $592 million to $652 million, and core EPS of $3.80 to $4.20. These are forecasts, not booked sales. The GAAP EPS range is $2.78 to $3.18. Its $1.02 per-share reconciliation includes expected amortization, stock compensation and restructuring. The wider annual opportunity does not remove those near-term costs.
The management scorecard is therefore prospective and measurable. Delivering the revenue objective earns credit only alongside margin and cash performance. Buybacks earn credit when they improve per-share economics without weakening the balance sheet during a funding-heavy ramp. Acquisition spending earns credit when the acquired capabilities generate returns above their financing and integration cost. The annual filing's customer concentration adds another constraint: the five largest customers represented about 36% of fiscal-year 2025 revenue, and the largest anonymous customer represented 16%. We do not assign that customer a name the filing does not disclose.
| Period | Growth % |
|---|---|
| Revenue | 23.77 |
| Core EPS | 34.07 |
| Adjusted FCF | 4.44 |
| Commitment | Current evidence | Next evaluation |
|---|---|---|
| FY2027 sales $44.5B | New guidance; $35.954B FY2026 base | Quarterly progress and program timing |
| Core margin6.1% | FY2026 rounded5.8% | Economic costs and segment disclosure |
| Adjusted FCF about$1.6B | FY2026$1.532B | Gross-capex cash and funding sources |
| Capital allocation | FY2026 buybacks$1.060B; acquisitions$852M | Net debt and per-share economics |
| Disclosure quality | New release preliminary unaudited | FY2026 10-K cash-flow notes |
The highest-ranked risk is a mismatch between production commitments and the timing of customer cash receipts. Its potential severity is high because the receivable, inventory and payable balances are large relative to annual cash generation. Its probability is not asserted as a statistical estimate. The practical signal is whether operating assets continue absorbing cash while liability support slows. That combination would challenge the valuation even if reported sales meet guidance.
The second risk is customer concentration and program timing. Manufacturing demand can shift across product generations, and capacity built for a particular program may not be redeployed immediately. The third risk is paying too much for earnings whose cash conversion has not matured. A high-quality business can deliver its plan and still produce a disappointing investment if the starting price assumes an even stronger outcome. The fourth is acquisition integration, including whether acquired capabilities generate sufficient returns after the initial cash outlay and ongoing compensation costs.
There is a genuine upside risk to our cautious value. Contractual arrangements may make the expanded working capital less risky than a balance-sheet snapshot suggests. Collections could catch up, infrastructure demand could stay stronger for longer, and buybacks could increase each remaining share's claim on that cash. Our bull case allows that combination, but does not treat it as the default. High uncertainty here means a wide plausible range of economic outcomes, not that every unfavorable scenario is equally likely or that management's outlook lacks credibility. We will change the conclusion when the cash and operating evidence changes.
| Rank | Risk | Early signal | Response |
|---|---|---|---|
| 1 | Working-capital reversal | Asset cash use outruns liability inflow | Reduce normalized owner-cash assumption |
| 2 | Customer/program concentration | Revenue delay; inventory persistence | Reassess margin and asset recoverability |
| 3 | Valuation compression | Guide delivered but lower market multiple | Maintain entry discipline |
| 4 | Acquisition execution | Weak returns after $852M outlay | Reassess economic profit adjustments |
| Upside | Faster collections and durable demand | Cash improves with margin | Raise cash forecast after evidence |
The next formal checkpoint is the fiscal-year 2026 annual filing, expected after this earnings release; the precise filing date is not assumed. We will review it in October 2026 for accounts-receivable sale arrangements, supplier and customer funding terms, acquisitions, contingent obligations and equity dilution. The annual report can explain the cash-flow mechanics more fully than the earnings exhibit. A footnote that resolves a funding concern would be evidence to update the thesis, while a newly disclosed obligation could make the current risk allowance inadequate.
The next operating checkpoint is the first-quarter fiscal-year 2027 release, with a review planned for December 2026 rather than an invented earnings appointment. Revenue and core EPS should be assessed against the company's published ranges. The cash checkpoint should use year-to-date comparisons and seasonal context, not demand an even quarter of the annual free-cash-flow guide. We would regard a reduction below the approximate $1.6 billion annual adjusted-cash objective as adverse, especially if the earnings objective remains intact and net debt rises.
A valuation review is also triggered if the stock approaches $240 while the operating thesis remains sound, or if evidence supports a higher sustainable owner-cash stream. The latter matters as much as a cheaper entry price: stronger cash can make an unchanged share price more attractive. Our thresholds are deliberately narrow enough to audit later. They are analytical review rules rather than company promises, and we will preserve today's baseline when grading the next quarter instead of moving the goalposts after the outcome is known.
| Test | Green evidence | Red evidence | Review date |
|---|---|---|---|
| Q1 revenue | $10.6B–$11.4B range delivered | Below$10.6B without offset | Dec2026 release review |
| Q1 core EPS | $3.80–$4.20 range delivered | Below$3.80 | Dec2026 release review |
| FY2027 adjusted FCF | About$1.6B guide maintained or raised | Guide below$1.5B | Each FY2027 update |
| Net funded debt | At/below$1.64B with cash progress | Above$2.0B without return case | Next filing review |
| Q4 funding explanation | Cash-use mechanics supported by footnotes | New unresolved obligations | Oct2026 annual review |
| Entry valuation | At/below$240 with intact thesis | Thesis breaks at any price | Continuous price review |
All statement figures in the data file are in millions of United States dollars, except per-share values, share counts and ratios explicitly labeled otherwise. Weighted-average share counts in the release are in millions. The chart labels retain those units: dollar formats used for financial aggregates mean millions, while stock-price and EPS charts use dollars per share. The underlying data preserves the source URL and original-column provenance for each of the nine quarters. Reconciliations are the company's own disclosed bridges, not estimates from a market-data vendor.
The cash-flow comparison uses fiscal years 2024, 2025 and 2026. The first two are supported by the filed annual report and the current year by the preliminary release. Adjusted free cash flow follows Jabil's definition, including property-sale proceeds and advances; gross-capex free cash flow is our separately labeled calculation. Neither measure subtracts business acquisitions. We treat acquisition spending separately rather than implying that all post-capex cash was distributed to shareholders. Balance-sheet debt and cash are point-in-time values; cash-flow changes exclude acquired net assets and therefore need not equal the raw balance-sheet changes.
The forward value uses management guidance as a starting point and analyst assumptions for multiples, owner cash, compensation reserve, discount rate, terminal growth and scenario probabilities. Probabilities express judgment and are not inferred from a statistical backtest. The pre-print close, intraday quote and historic analyst snapshots each retain their own date and purpose. Current-quarter segment details not supplied in the release remain explicitly unavailable. There is no invented fourth-quarter split, future publication link or completed annual audit. The raw sources and calculation builder are retained so that every key conclusion can be rebuilt and challenged.
| Source | Period / date | Purpose |
|---|---|---|
| SEC Item2.02 Ex99.1 | 2026-09-30; Q4/FY2026 | New results, guidance, cash, reconciliation |
| SEC10-Q | 2026-06-30; May31 period | Latest filed segments and financing notes |
| SEC10-K | 2025-10-17; FY2025 | Audited structure and annual comparisons |
| Prior SEC earnings exhibits | FY2024Q4–FY2026Q3 | Nine-quarter income and non-GAAP history |
| SEC companyfacts | Saved Sep30 | Tagged issuer balance-sheet cross-checks |
| FMP saved snapshots | Sep30; price history throughSep29 | Market prices, shares, consensus and dated targets |
Primary release: Jabil fourth-quarter and fiscal-year 2026 results. Annual context: FY2025 Form10-K. Latest quarterly detail: May31 FY2026 Form10-Q. Market snapshot provenance is retained with credential-free provider URLs. Full research and subsequent episode updates are available at chargedalpha.com.